← Leaderboards
Erica Dhuey
University Of Pennsylvania
$120,651
Attributed
$120,651
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.5K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$120,651 · 1
By mechanism
F31$120,651 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mitchell A. Lazar$48,884,193
- Klaus H. Kaestner$80,959,526
- Stephen J Moss$27,715,767
- Ali Naji$46,943,355
- Doris A. Stoffers$30,246,196
Others in their field
Other Emerging Leaders on “Congenic”
- Daniel J Lerner · Senseion Therapeutics, Inc.$3,328,144
- Timothy Newhouse · Yale University$3,085,797
- George R Uhl · National Institute On Drug Abuse$2,845,378
- Jason L Kubinak · University Of Texas Arlington$2,463,326
- Carmen Bergom · Medical College Of Wisconsin$2,342,587
- Norman Taylor · Massachusetts General Hospital$2,118,216
Research focus
CongenicCongenic MiceAffinityAdoptive TransferAffectAblationAntigensAntitumor EffectAftercareAutoantigensBaseBioinformaticsBlocking AntibodiesBreastCancer ImmunotherapyCancer TherapyCancer TypeCell PhysiologyCellsCentral ToleranceClinicClinical ResearchCombined Modality TherapyData Set
Grant awards (3)
The role of the T cell repertoire in immune checkpoint blockade therapy$32,083
F31 · FY2019 · CA · contact PI
The role of the T cell repertoire in immune checkpoint blockade therapy$44,524
F31 · FY2018 · CA · contact PI
The role of the T cell repertoire in immune checkpoint blockade therapy$44,044
F31 · FY2017 · CA · contact PI